Serotonin (1A) receptor involvement in acute 3,4- methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 5, 2005, Pages 648-657

  Morley, Kirsten C ^a   Arnold, Jonathon C ^b   McGregor, Iain S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

5 HT; 5 HT1A; 5 HT1B:5 HT2B; 5 HT2C; Anxiety; MDMA; Social interaction

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ILLICIT DRUG; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RECEPTOR SUBUNIT; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2B RECEPTOR ANTAGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BODY POSTURE; CONTROLLED STUDY; FACILITATION; HYPERACTIVITY; MALE; MICROANALYSIS; NONHUMAN; PHARMACOLOGICAL BLOCKING; PSYCHOPHARMACOLOGY; RAT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; REFLEX; SEROTONIN SYNDROME; SOCIAL INTERACTION;

ANIMALS; HALLUCINOGENS; INDOLES; INTERPERSONAL RELATIONS; KETANSERIN; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS; SEROTONIN SYNDROME;

EID: 21244431683     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.04.009     Document Type: Article

References (71)

1. M.E. Albonetti, and F. Farabollini Effects of single and repeated restraint on the social behaviour of rats Physiol. Behav. 53 1993 937 942
2. N. Andrews, S. Hogg, L.E. Gonzalez, and S.E. File 5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively Eur. J. Pharmacol. 264 1994 259 264
3. M.G. Bankson, and K.A. Cunningham Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors Neuropsychopharmacology 26 2002 40 52
4. S.K. Bhattacharya, A. Bhattacharya, and S. Ghosal Anxiogenic activity of methylenedioxymethaphetamine (ecstasy)-an experimental study Biog. Amines 14 1998 217 237
5. M.J. Bickerdike, A. Fletcher, and C.A. Marsden Attenuation of CCK-induced aversion in rats on the elevated x-maze by the selective 5-HT1A receptor antagonists (+) WAY100135 and WAY100635 Neuropharmacology 34 1995 805 811
6. R.J. Blanchard, and D.C. Blanchard Attack and defense in rodents as ethoexperimental models for the study of emotion Prog. Neuro-Psychopharmacol. Biol. Psychiatry 13 1989 S3 S14 (Suppl.)
7. D. Brunner, M.C. Buhot, R. Hen, and M. Hofer Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice Behav. Neurosci. 113 1999 587 601
8. C.W. Callaway, L.L. Wing, and M.A. Geyer Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats J. Pharmacol. Exp. Ther. 254 1990 456 464
9. C.W. Callaway, G.A. Johnston, L.H. Gold, D.E. Nichols, and M.A. Geyer Ampethamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists Psychopharmacology 104 1991 293 301
10. C.W. Callaway, N. Rempel, R.Y. Peng, and M.A. Geyer Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4- methylenedioxymethamphetamine Neuropsychopharmacology 5 1992 113 127
11. A. Capurro, M. Reyes-Parada, D. Olazabal, R. Perrone, R. Silveira, and O. Macadar Aggressive behavior and jamming avoidance response in the weakly electric fish Gymnotus carapo: effects of 3,4-methylenedioxymethamphetamine (MDMA) Comp. Biochem. Physiol. 110 1997 367 376
12. D.S. Charney, S.W. Woods, W.K. Goodman, and G.R. Heninger Serotonin function in anxiety: II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects Psychopharmacology 92 1987 14 24
13. N. Collinson, and G.R. Dawson On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635, Psychopharmacology 132 1997 35 43
14. J.L. Cornish, Z. Shahnawaz, M.R. Thompson, S. Wong, K.C. Morley, G.E. Hunt, and I.S. McGregor Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats Eur. J. Pharmacol. 482 2003 339 341
15. S.F. de Boer, M. Lesourd, E. Mocaer, and J.M. Koolhaas Somatodendritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptor agonists in rats: an ethopharmacological study with S-15535, alnespirone, and WAY-100635 Neuropsychopharmacology 23 2000 20 33
16. G. Diaz-Veliz, T. Alarcon, C. Espinoza, N. Dussaubat, and S. Mora Ketanserin and anxiety levels: influence of gender, estrous cycle, ovariectomy and ovarian hormones in female rats Pharmacol. Biochem. Behav. 58 1997 637 642
17. M.S. Duxon, G.A. Kennett, S. Lightowler, T.P. Blackburn, and K.C. Fone Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat Neuropharmacology 36 1997 601 608
18. J. Eguchi, Y. Inomata, and K. Saito The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism Pharmacol. Biochem. Behav. 68 2001 677 683
19. S.E. File The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs J. Neurosci. Methods 2 1980 219 238
20. S.E. File, and P. Seth A review of 25 years of the social interaction test Eur. J. Pharmacol. 463 2003 35 53
21. S.E. File, L.E. Gonzalez, and N. Andrews Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests J. Neurosci. 16 1996 4810 4815
22. M. Filip, E. Nowak, I. Palpa, and E. Przegalinski Role of 5-hydroxytryptamine1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats J. Physiol. Pharmacol. 52 2001 249 263
23. P.J. Fletcher, K.M. Korth, S.R. Robinson, and G.B. Baker Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement Psychopharmacology 162 2002 282 291
24. L.H. Gold, and G.F. Koob Methysergide potentiates the hyperactivity produced by MDMA in rats Pharmacol. Biochem. Behav. 29 1988 645 648
25. L.H. Gold, G.F. Koob, and M.A. Geyer Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats J. Pharmacol. Exp. Ther. 247 1988 547 555
26. G.M. Goodwin, R.J. De Souza, A.R. Green, and D.J. Heal The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n- propylamino)tetralin (8-OH-DPAT) Psychopharmacology 91 1987 506 511
27. E.C. Grant, and J.H. MacKintosh A comparison of the social postures of some common laboratory rodents Behaviour 21 1963 246 259
28. A.R. Green, and I.S. McGregor On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA Psychopharmacology 162 2002 448 450
29. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA Ecstasy) Pharmacol. Rev. 55 2003 463 508
30. G. Griebel, R.J. Rodgers, G. Perrault, and D.J. Sanger Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test Pharmacol. Biochem. Behav. 57 1997 817 827
31. M. Hiramatsu, T. Nabeshima, T. Kameyama, Y. Maeda, and A.K. Cho The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats Pharmacol. Biochem. Behav. 33 1989 343 347
32. D. Hoyer, J.P. Hannon, and G.R. Martin Molecular, pharmacological and functional diversity of 5-HT receptors Pharmacol. Biochem. Behav. 71 2002 533 554
33. S. Koch, and M.P. Galloway MDMA induced dopamine release in vivo: role of endogenous serotonin J. Neural Transm. 104 1997 135 146
34. C.L. Kutscher, and B.K. Yamamoto A frequency analysis of behavior components of the serotonin syndrome produced by p-chloroamphetamine Pharmacol. Biochem. Behav. 11 1979 611 616
35. M.B. Liester, C.S. Grob, G.L. Bravo, and R.N. Walsh Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use J. Nerv. Ment. Dis. 180 1992 345 352 (discussion 353-344)
36. D. Lin, and L.H. Parsons Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze Pharmacol. Biochem. Behav. 71 2002 581 587
37. H.Q. Lin, P.M. Burden, M.J. Christie, and G.A.R. Johnston The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine Pharmacol. Biochem. Behav. 62 1999 403 408
38. E. Maldonado, and J.F. Navarro Effects of 3,4-methylenedioxy- methamphetamine (MDMA) on anxiety in mice tested in the light-dark box Prog. Neuro-Psychopharmacol. Biol. Psychiatry 24 2000 463 472
39. E. Maldonado, and J.F. Navarro MDMA ("ecstasy") exhibits an anxiogenic-like activity in social encounters between male mice Pharmacol. Res. 44 2001 27 31
40. U.D. McCann, and G.A. Ricaurte MDMA ("ecstasy") and panic disorder: induction by a single dose Biol. Psychiatry 32 1992 950 953
41. A.C. McCreary, M.G. Bankson, and K.A. Cunningham Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/ 1D) receptors J. Pharmacol. Exp. Ther. 290 1999 965 973
42. D.J. McKenna, and S.J. Peroutka Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") J. Neurochem. 54 1990 14 22
43. T.F. Meert, W. Melis, N. Aerts, and G. Clincke Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats Behav. Pharmacol. 8 1997 353 363
44. K.C. Morley, and I.S. McGregor (+/-)-3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats Eur. J. Pharmacol. 408 2000 41 49
45. J.F. Navarro, and E. Maldonado Behavioral, profile of 3,4-methylenedioxy-methamphetamine (MDMA) in agonistic encounters between male mice Prog. Neuro-Psychopharmacol. Biol. Psychiatry 23 1999 327 334
46. J.F. Navarro, and E. Maldonado Acute and subchronic effects of MDMA (ecstasy) on anxiety in male mice tested in the elevated plus-maze Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 2002 1151 1154
47. C.L. Parks, P.S. Robinson, E. Sibille, T. Shenk, and M. Toth Increased anxiety of mice lacking the serotonin1A receptor Proc. Natl. Acad. Sci. U. S. A. 95 1998 10734 10739
48. S.J. Peroutka Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brain Brain Res. 344 1985 167 171
49. O. Picazo, C. Lopez-Rubalcava, and A. Fernandez-Guasti Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action Brain Res. Bull. 37 1995 169 175
50. D.J. Rademacher, A.L. Schuyler, C.K. Kruschel, and R.E. Steinpreis Effects of cocaine and putative atypical antipsychotics on rat social behavior: an ethopharmacological study Pharmacol. Biochem. Behav. 73 2002 769 778
51. M. Razzoli, B.S. Cusing, C. SueCarter, and P. Valsecchi Hormonal regulation of agonistic and affiliative behavior in female Mongolian gerbils (Meriones unguiculatus) Horm. Behav. 43 2003 549 553
52. N.L. Rempel, C.W. Callaway, and M.A. Geyer Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release Neuropsychopharmacology 8 1993 201 211
53. L.A. Riblet, D.P. Taylor, M.S. Eison, and H.C. Stanton Pharmacology and neurochemistry of buspirone J. Clin. Psychiatry 43 1982 11 18
54. G. Rudnick, and S.C. Wall The molecular mechanism of ecstasy [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release Proc. Natl. Acad. Sci. U. S. A. 89 1992 1817 1821
55. K. Scearce-Levie, S.S. Viswanathan, and R. Hen Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor Psychopharmacology 141 1999 154 161
56. J.C. Schank, and J.R. Alberts Self-organized huddles of rat pups modeled by simple rules of individual behavior J. Theor. Biol. 189 1997 11 25
57. F. Schifano A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities Psychopharmacology 173 2004 242 248
58. M. Shankaran, and G.A. Gudelsky A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration Psychopharmacology 147 1999 66 72
59. N. Solowij, W. Hall, and N. Lee Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug Br. J. Addict. 87 1992 1161 1172
60. L.J. Spanos, and B.K. Yamamoto Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat Pharmacol. Biochem. Behav. 32 1989 835 840
61. J.J. Sramek, E.J. Frackiewicz, and N.R. Cutler Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety Clin. Ther. 19 1997 498 506
62. C.P. Stephenson, G.E. Hunt, A.N. Topple, and I.S. McGregor The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain Neuroscience 92 1999 1011 1023
63. R.N. Takahashi, O. Berton, P. Mormede, and F. Chaouloff Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze Braz. J. Med. Biol. Res. 34 2001 675 682
64. M.D. Tricklebank, C. Forler, and J.R. Fozard The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat Eur. J. Pharmacol. 106 1984 271 282
65. F.X. Vollenweider, A. Gamma, M. Liechti, and T. Huber Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers Neuropsychopharmacology 19 1998 241 251
66. C.J. Wallis, and H. Lal A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety Prog. Neuro-Psychopharmacol. Biol. Psychiatry 22 1998 547 565
67. P.M. Whitaker-Azmitia, and T.A. Aronson "Ecstasy" (MDMA)-induced panic Am. J. Psychiatr. 146 1989 119
68. J.T. Winslow, and T.R. Insel Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists Psychopharmacology 105 1991 513 520
69. J.M. Zanoveli, R.L. Nogueira, and H. Zangrossi Jr. Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze Eur. J. Pharmacol. 473 2003 153 161
70. Z.J. Zhang, D.E. Schmidt, T. de Paulis, B.L. Trivedi, E.S. Onaivi, M.H. Ebert, and W.A. Hewlett Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze Pharmacol. Biochem. Behav. 69 2001 571 578
71. X. Zhuang, C. Gross, L. Santarelli, V. Compan, A.C. Trillat, and R. Hen Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors Neuropsychopharmacology 21 1999 52S 60S